Neurological manifestation of cancer – paraneoplastic syndromes

• Main Authors: Szklener Katarzyna, Mandziuk Slawomir
• Format: Article
• Language: English
• Published: Sciendo 2021-06-01
• Series: Current Issues in Pharmacy and Medical Sciences
• Subjects: neurological paraneoplastic syndromes; cancer; antineural antibodies
• Online Access: https://doi.org/10.2478/cipms-2021-0018

Neurological paraneoplastic syndromes (NPS) belong to a heterogeneous group of disorders affecting the nervous system. NPS occur as a result of immunological reaction to the tumor. As a result, the isolated syndrome is formed and manifests itself in many different ways, for example: limbic encephalitis, ataxia, dominant cerebellar degeneration, psychiatric disturbances, myasthenia gravis or diffuse encephalomyelitis. Detection of NPS is solely based on the presence of specific anti-neural antibodies. Although NPS had been previously considered unresponsive to therapy, some research has shown that there are effective therapies, including cancer- and immunotherapy targeted therapies.